References of "De Leval, X"
     in
Bookmark and Share    
Full Text
Peer Reviewed
See detailThe use of nimesulide and its analogues in cancer chemoprevention
Renard, Jean-François ULg; Julémont, F.; De Leval, X. et al

in Anti-Cancer Agents in Medicinal Chemistry (2006), 6

Detailed reference viewed: 17 (1 ULg)
Full Text
Peer Reviewed
See detailStructure-based pharmacophore of COX-2 selective inhibitors and identification of original lead compounds from 3D database searching method
Michaux, C.; De Leval, X.; Julémont, F. et al

in European Journal of Medicinal Chemistry (2006), 41

Detailed reference viewed: 30 (0 ULg)
Peer Reviewed
See detailDéveloppement de modulateurs de la voie du thromboxane A2 en tant qu’agents anti-angiogéniques et anti-métastatiques
De Leval, X.; Dassesse, T.; Dogne, J. M. et al

Poster (2005, May)

Detailed reference viewed: 8 (1 ULg)
Full Text
Peer Reviewed
See detailA new potential cyclooxygenase-2 inhibitor, pyridinic analogue of nimesulide
Michaux, C.; Charlier, C.; Julémont, F. et al

in European Journal of Medicinal Chemistry (2005), 40

Detailed reference viewed: 2 (1 ULg)
Peer Reviewed
See detailPharmacophore generation to design new leads for selective cyclooxygenase-2 inhibition
Michaux, C.; Julemont, F.; De Leval, X. et al

Poster (2004, October 07)

Detailed reference viewed: 10 (0 ULg)
Full Text
Peer Reviewed
See detailModulation of the arachidonic cascade with omega 3 fatty acids or analogues: Potential therapeutic benefits
Roland, Isabelle ULg; de Leval, X.; Evrard, Brigitte ULg et al

in Mini-Reviews in Medicinal Chemistry (2004), 4(6), 659-668

Increasing interest in the role of omega 3 fatty acids has arisen in these latest years since evidence of their implication in the cardioprotective fish based diet of the Inuit has been demonstrated ... [more ▼]

Increasing interest in the role of omega 3 fatty acids has arisen in these latest years since evidence of their implication in the cardioprotective fish based diet of the Inuit has been demonstrated. Furthermore, several in vitro, in vivo and epidemiological studies support the benefit of this fatty acids intake in various pathological states such as in the cardiovascular, cancer, inflammation, psychiatric, paediatric, pulmonary, dermatological and ophthalmologic fields. This review will focus on metabolism and pharmacological implication of w3 fatty acids intake as well as its interest in the prevention or treatment of the above-mentioned pathologies. [less ▲]

Detailed reference viewed: 43 (8 ULg)
Peer Reviewed
See detailIdentification d’inhibiteurs sélectifs de la cyclooxygénase-2 (COX-2)
Michaux, C.; Julemont, F.; De Leval, X. et al

Conference (2004, June)

Detailed reference viewed: 14 (0 ULg)
Peer Reviewed
See detailIdentification d’un inhibiteur COX-2 sélectif », 18èmes Journées Franco-belges de Pharmacochimie
Michaux, C.; Julemont, F.; De Leval, X. et al

Poster (2004, June)

Detailed reference viewed: 7 (0 ULg)
Peer Reviewed
See detailSynthèse et évaluation pharmacologique d’analogues pyridiniques du nimésulide : variation du pont « inter-cycle
Julemont, F.; De Leval, X.; Dogne, J. M. et al

Poster (2004, June)

Detailed reference viewed: 5 (0 ULg)
Peer Reviewed
See detailDevelopment of thromboxane A2 modulators as promising anti-metastatic and anti-angiogenic compounds
De Leval, X.; Dassesse, T.; Benoit, V. et al

Conference (2004, May)

Detailed reference viewed: 5 (0 ULg)
Full Text
Peer Reviewed
See detailNew developments on thromboxane modulators
Dogné, Jean-Michel ULg; Hanson, Julien ULg; De leval, X. et al

in Mini Reviews in Medicinal Chemistry (2004)

Detailed reference viewed: 19 (3 ULg)
Full Text
Peer Reviewed
See detailEffects of COX-2 inhibitors on ROS produced by Chlamydia pneumoniae-primed human promonocytic cells (THP-1)
Mouithys-Mickalad, Ange ULg; Deby, Ginette ULg; Dogné, Jean-Michel ULg et al

in Biochemical and Biophysical Research Communications (2004), 325(4), 1122-1130

Chronic inflammation through foam cells and macrophages is important in atherosclerosis development, and can be considered as therapeutic targets. Cyclooxygenase and NADPH-oxidase were expressed within ... [more ▼]

Chronic inflammation through foam cells and macrophages is important in atherosclerosis development, and can be considered as therapeutic targets. Cyclooxygenase and NADPH-oxidase were expressed within atherosclerotic lesions. Reactive oxygen species produced by NADPH oxidase were found to trigger the cyclooxygenase-2 expression. The effects of preferential COX-2 inhibitors on ROS produced by Chlamydia-primed human monocytes (THP-1 cells) were evaluated by fluorescence, chemiluminescence, oxymetry, and EPR spin trapping. Fluorescence assays showed an increased production of ROS with Chlamydia versus cells primed by 10(-8) M PMA. COX-2 inhibitors inhibited in a dose-dependent manner the luminol-enhanced CL while ibuprofen and diclofenac increased the chemiluminescence response. By EPR spin trapping, COX-2 inhibitors, ibuprofen, and diclofenac, exhibited a dose-dependent inhibiting effect (10 and 100 muM) on the EPR signal appearance. Our cell model combining EPR, chemiluminescence, and oxymetry appeared relevant to study the modulating effects of preferential COX-2 inhibitors on the cell oxidant activity and chronic inflammatory diseases. (C) 2004 Elsevier Inc. All rights reserved. [less ▲]

Detailed reference viewed: 125 (36 ULg)
Full Text
Peer Reviewed
See detailNew developments on thromboxane and prostacyclin modulators. Part II: prostacyclin modulators
De Leval, X.; Hanson, Julien ULg; David, Jean-Louis ULg et al

in Current Medicinal Chemistry (2004), 11

Detailed reference viewed: 21 (1 ULg)
Full Text
Peer Reviewed
See detailFirst and second generations of COX-2 selective inhibitors
De leval, X.; Julémont, F.; Benoit, V. et al

in Mini Reviews in Medicinal Chemistry (2004), 4

Detailed reference viewed: 25 (4 ULg)
Full Text
Peer Reviewed
See detailCharacterization of preferential activity on platelet thromboxane A2 receptors of BM-613, a new thromboxane A2 antagonist
Hanson, Julien ULg; Rolin, S.; De Leval, X. et al

in Fundamental & Clinical Pharmacology (2004)

Detailed reference viewed: 3 (1 ULg)
Full Text
Peer Reviewed
See detailNew developments on thromboxane and prostacyclin modulators. Part I: thromboxane modulators
Dogné, Jean-Michel ULg; De leval, X.; Hanson, Julien ULg et al

in Current Medicinal Chemistry (2004), 11

Detailed reference viewed: 21 (2 ULg)